Nature Communications (Jul 2021)

The integrated stress response is tumorigenic and constitutes a therapeutic liability in KRAS-driven lung cancer

  • Nour Ghaddar,
  • Shuo Wang,
  • Bethany Woodvine,
  • Jothilatha Krishnamoorthy,
  • Vincent van Hoef,
  • Cedric Darini,
  • Urszula Kazimierczak,
  • Nicolas Ah-son,
  • Helmuth Popper,
  • Myriam Johnson,
  • Leah Officer,
  • Ana Teodósio,
  • Massimo Broggini,
  • Koren K. Mann,
  • Maria Hatzoglou,
  • Ivan Topisirovic,
  • Ola Larsson,
  • John Le Quesne,
  • Antonis E. Koromilas

DOI
https://doi.org/10.1038/s41467-021-24661-0
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 15

Abstract

Read online

The Integrated Stress Response (ISR) is a cytoprotective pathway upregulated in many cancers. Here the authors show that the activation of PERK/p-eIF2α arm of ISR enhances ERK phosphorylation through translation repression of DUSP6, thus resulting in KRAS-driven lung tumorigenesis.